JPWO2021032997A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021032997A5 JPWO2021032997A5 JP2022511190A JP2022511190A JPWO2021032997A5 JP WO2021032997 A5 JPWO2021032997 A5 JP WO2021032997A5 JP 2022511190 A JP2022511190 A JP 2022511190A JP 2022511190 A JP2022511190 A JP 2022511190A JP WO2021032997 A5 JPWO2021032997 A5 JP WO2021032997A5
- Authority
- JP
- Japan
- Prior art keywords
- asparaginase
- use according
- optionally
- conjugate
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1912020.3A GB201912020D0 (en) | 2019-08-21 | 2019-08-21 | Therapeutic Conjugate |
| GB1912020.3 | 2019-08-21 | ||
| PCT/GB2020/052022 WO2021032997A1 (en) | 2019-08-21 | 2020-08-21 | Therapeutic conjugate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545253A JP2022545253A (ja) | 2022-10-26 |
| JPWO2021032997A5 true JPWO2021032997A5 (ru) | 2023-08-29 |
Family
ID=68099464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022511190A Pending JP2022545253A (ja) | 2019-08-21 | 2020-08-21 | 治療用コンジュゲート |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220331411A1 (ru) |
| EP (2) | EP4368251A2 (ru) |
| JP (1) | JP2022545253A (ru) |
| KR (1) | KR20220050934A (ru) |
| CN (1) | CN114450029A (ru) |
| AU (1) | AU2020332081A1 (ru) |
| BR (1) | BR112022003126A2 (ru) |
| CA (1) | CA3151718A1 (ru) |
| GB (1) | GB201912020D0 (ru) |
| IL (1) | IL290747A (ru) |
| WO (1) | WO2021032997A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220313798A1 (en) * | 2021-03-30 | 2022-10-06 | Jazz Pharmaceuticals Ireland Ltd. | Dosing of recombinant l-asparaginase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20171180T4 (hr) * | 2009-07-06 | 2023-06-09 | Jazz Pharmaceuticals Ii Sas | Pegilirana l-asparaginaza |
| WO2011003633A1 (en) * | 2009-07-06 | 2011-01-13 | Alize Pharma Ii | Pegylated l-asparaginase |
| SG11202003614WA (en) * | 2017-10-27 | 2020-05-28 | Pfenex Inc | Method for production of recombinant e. coli asparaginase |
| AU2018375183A1 (en) * | 2017-11-30 | 2020-06-25 | Jazz Pharmaceuticals Ireland Ltd. | Methods of treatment with asparaginase |
-
2019
- 2019-08-21 GB GBGB1912020.3A patent/GB201912020D0/en not_active Ceased
-
2020
- 2020-08-21 EP EP24152887.6A patent/EP4368251A2/en active Pending
- 2020-08-21 WO PCT/GB2020/052022 patent/WO2021032997A1/en active Application Filing
- 2020-08-21 AU AU2020332081A patent/AU2020332081A1/en active Pending
- 2020-08-21 JP JP2022511190A patent/JP2022545253A/ja active Pending
- 2020-08-21 KR KR1020227009029A patent/KR20220050934A/ko unknown
- 2020-08-21 EP EP20765071.4A patent/EP4017525A1/en active Pending
- 2020-08-21 BR BR112022003126A patent/BR112022003126A2/pt unknown
- 2020-08-21 US US17/635,942 patent/US20220331411A1/en active Pending
- 2020-08-21 CA CA3151718A patent/CA3151718A1/en active Pending
- 2020-08-21 CN CN202080065507.9A patent/CN114450029A/zh active Pending
-
2022
- 2022-02-20 IL IL290747A patent/IL290747A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | PEGylation of bacteriophages increases blood circulation time and reduces T‐helper type 1 immune response | |
| US6821521B1 (en) | Multicomponent meningococcal vaccine | |
| Castro | Antitumour effects of Corynebacterium parvum in mice | |
| US10576138B2 (en) | Vaccines and compositions for the prevention of Salmonella infections | |
| JP2000504032A (ja) | 多価ｄｔｐポリオワクチン | |
| JP2011190278A (ja) | 粘膜体表面に接触させてワクチン抗原を包含する物質の効果を調節する新規非抗原性粘膜アジュバント処方 | |
| JPH085804B2 (ja) | Ａ型及びｂ型肝炎混合アジュバントワクチン | |
| EP3478300B1 (en) | Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells | |
| Elsadek et al. | Immunological responses to PEGylated proteins: anti-PEG antibodies | |
| JP5179521B2 (ja) | ペグ‐インターフェロンアルファ接合体および凍結保護剤としてラフィノースを含む組成物 | |
| AU2014313699A1 (en) | A bacterial vaccine and methods for manufacture thereof | |
| US7332307B2 (en) | Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense system | |
| JP7085482B2 (ja) | スタフィロコッカス感染症のための凍結乾燥製剤を製造する方法 | |
| Maeda et al. | Improvement of pharmacological properties of protein-drugs by tailoring with synthetic polymers | |
| US7479283B1 (en) | Acellular pertussis vaccine comprising a combination of the 69 kDa and the filamentous haemagglutinin antigens of Bordetella pertussis | |
| JPWO2021032997A5 (ru) | ||
| US20030215469A1 (en) | Multicomponent meningococcal vaccine | |
| US20100311656A1 (en) | Treatment or prevention of respiratory viral infections with alpha thymosin peptides | |
| AU2005244826B2 (en) | Treatment or prevention of respiratory viral infections with immunomodulator compounds | |
| KR20150020164A (ko) | 보강제 제형 및 방법 | |
| Gaballa et al. | Treatment-induced and pre-existing anti-PEG antibodies: prevalence, clinical implications, and future perspectives | |
| MXPA05011304A (es) | Composiciones a base de peptidos de alfa timosina para el tratamiento y prevencion de infecciones virales respiratorias. | |
| EP0699078B1 (en) | A method to prevent side effects and insensitivity to the therapeutic uses of toxins | |
| EP0028815A2 (en) | The use of ricin and a pharmaceutical composition containing the same for increasing the immune response | |
| JP6530768B2 (ja) | サイトカイン−キトサンバイオコンジュゲート及びその使用方法 |